9-35657838-C-T
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 10P and 1B. PM2PP5_Very_StrongBP4
The NR_003051.4(RMRP):n.182G>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000231 in 693,312 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: 𝑓 0.000028 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000022 ( 0 hom. )
Consequence
RMRP
NR_003051.4 non_coding_transcript_exon
NR_003051.4 non_coding_transcript_exon
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0390
Genes affected
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 9-35657838-C-T is Pathogenic according to our data. Variant chr9-35657838-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 928881.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-35657838-C-T is described in Lovd as [Likely_pathogenic].
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48). . Strength limited to SUPPORTING due to the PP5.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RMRP | NR_003051.4 | n.182G>A | non_coding_transcript_exon_variant | 1/1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RMRP | ENST00000363046.1 | n.180G>A | non_coding_transcript_exon_variant | 1/1 | 6 |
Frequencies
GnomAD3 genomes AF: 0.0000275 AC: 4AN: 145276Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
4
AN:
145276
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000461 AC: 6AN: 130180Hom.: 0 AF XY: 0.0000281 AC XY: 2AN XY: 71116
GnomAD3 exomes
AF:
AC:
6
AN:
130180
Hom.:
AF XY:
AC XY:
2
AN XY:
71116
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000219 AC: 12AN: 548036Hom.: 0 Cov.: 0 AF XY: 0.0000135 AC XY: 4AN XY: 296766
GnomAD4 exome
AF:
AC:
12
AN:
548036
Hom.:
Cov.:
0
AF XY:
AC XY:
4
AN XY:
296766
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000275 AC: 4AN: 145276Hom.: 0 Cov.: 33 AF XY: 0.0000422 AC XY: 3AN XY: 71062
GnomAD4 genome
AF:
AC:
4
AN:
145276
Hom.:
Cov.:
33
AF XY:
AC XY:
3
AN XY:
71062
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Metaphyseal chondrodysplasia, McKusick type Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Oct 24, 2022 | Variant summary: RMRP n.181G>A alters a nucleotide in the non-coding RNA and was at the nucleotides involved in base pairing in the secondary structure of the RNA molecule, compromising the hairpin structure topology (Gomes_2019). Also, this variant was located in P12 domain which is important region for binding POP1 and RPP38 to the RNA molecule (PMID: 15096576). The variant allele was found at a frequency of 4.6e-05 in 130180 control chromosomes (gnomAD). n.181G>A has been reported in the literature in individuals affected with Cartilage-Hair Hypoplasia (Ridanpaa 2002, Hermanns 2005, Hermanns 2006, Castilla-Cortazar 2017, Gomes_2019). These data indicate that the variant is very likely to be associated with disease. At least one publication reported experimental evidence evaluating an impact on RMRP expression. The most pronounced variant effect results in 10%-<30% of normal RMRP expression (Hermanns 2005). One ClinVar submitter (evaluation after 2014) cites the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Anauxetic dysplasia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 10, 2023 | This variant occurs in the RMRP gene, which encodes an RNA molecule that does not result in a protein product. This variant is present in population databases (no rsID available, gnomAD 0.03%). This variant has been observed in individual(s) with clinical features of cartilage-hair hypoplasia anauxetic dysplasia spectrum disorders (PMID: 16254002, 16838329, 27862957). This variant is also known as 180G>A and c.-542C>C/T. ClinVar contains an entry for this variant (Variation ID: 928881). For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at